FDA Inspection 1093466 — Quest Diagnostics

Quest Diagnostics — FEI 3005821736

The FDA completed an inspection of Quest Diagnostics on May 23, 2019 in Lenexa, KS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 23, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lenexa, KS (United States)

Additional details

Clinical BA/BE

Need the full FDA record for Quest Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.